Latest Period
Q1 2026
Security Snapshot
Ensysce Biosciences, Inc. - Common Stock, par value $0.0001 per share (ENSC) Institutional Ownership
CUSIP: 293602504
13F Institutional Holders and Ownership History from Q4 2024 to Q1 2026
Institutions Reporting
15
Shares (Excl. Options)
487,010
Price
$0.54
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Symbol
- ENSC on Nasdaq
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 487,010
- Total 13F value
- $261,485
- Portfolio coverage rank
- 0%
- Share change
- -15,610
- Value change
- -$79,212
- Number of holders
- 15
- Shares outstanding
- 2,371,778
- SEC-reported price per share
- $0.29
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
2 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- ENSC - Ensysce Biosciences, Inc. - Common Stock, par value $0.0001 per share is tracked under CUSIP 293602504.
- 15 institutions reported positions in Q1 2026.
- 2 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 17 to 15 between Q4 2025 and Q1 2026.
- SEC-reported value moved from $461,118 to $261,485.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 15 institutions filings for Q1 2026.
Security key
293602504
Latest holder period
Q1 2026
13F holders
15
13D/G owners
2
CIK / CUSIP context first
Open Q1 2026 holders
ENSC full holder history
Ensysce Biosciences, Inc. SEC filings
Ensysce Biosciences, Inc. company facts
Ensysce Biosciences, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 293602504:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
2
Security
ENSC
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC | 3.7% | $264,331 | 86,666 | 0% | Perceptive Advisors LLC | 31 Mar 2025 | ||
| Adage Capital Management, L.P. | 3.2% | -43% | $167,353 | 74,711 | 0% | Adage Capital Management, L.P. | 30 Jun 2025 |
As of 31 Mar 2026, 15 institutional investors reported holding 487,010 shares of Ensysce Biosciences, Inc. - Common Stock, par value $0.0001 per share (ENSC). This represents 21% of the company’s total 2,371,778 outstanding shares.
13F concentration
Top 22 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
21%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 6.3% | 149,711 | 0% | 0% | $80,619 |
| PERCEPTIVE ADVISORS LLC | 3.7% | 86,666 | 0% | 0% | $46,670 |
| GEODE CAPITAL MANAGEMENT, LLC | 3.1% | 73,880 | +234% | 0% | $39,784 |
| CITADEL ADVISORS LLC | 2.4% | 57,363 | 0% | $30,890 | |
| XTX Topco Ltd | 1% | 24,363 | 0% | $13,119 | |
| VANGUARD FIDUCIARY TRUST CO | 1% | 23,854 | 0% | 0% | $12,857 |
| JANE STREET GROUP, LLC | 0.57% | 13,570 | 0% | $7,308 | |
| Virtu Financial LLC | 0.56% | 13,313 | 0% | $7,000 | |
| TRU INDEPENDENCE ASSET MANAGEMENT 2, LLC | 0.55% | 13,000 | +8.3% | 0% | $7,001 |
| VANGUARD CAPITAL MANAGEMENT LLC | 0.54% | 12,854 | 0% | 0% | $6,928 |
| UBS Group AG | 0.37% | 8,791 | +8691% | 0% | $4,730 |
| Tower Research Capital LLC (TRC) | 0.26% | 6,094 | +15% | 0% | $3,282 |
| FNY Investment Advisers, LLC | 0.13% | 3,000 | 0% | 0% | $1,000 |
| SBI Securities Co., Ltd. | 0.02% | 486 | +15% | 0% | $262 |
| BlackRock, Inc. | 0% | 65 | 0% | 0% | $35 |
| JONES FINANCIAL COMPANIES LLLP | 0% | 0 | -100% | $0 | |
| DRW Securities, LLC | 0% | 0 | -100% | $0 | |
| Financial Plan, Inc. | 0% | 0 | -100% | $0 | |
| HRT FINANCIAL LP | 0% | 0 | -100% | $0 | |
| Williams & Novak, LLC | 0% | 0 | -100% | $0 | |
| TWO SIGMA SECURITIES, LLC | 0% | 0 | -100% | $0 | |
| BANK OF AMERICA CORP /DE/ | 0% | 0 | -100% | $0 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
6
Latest
Q1 2026
Rows shown
1-6 of 6
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 487,010 | $261,485 | -$79,212 | $0.54 | 15 |
| 2025 Q4 | 502,620 | $461,118 | +$35,780 | $0.92 | 17 |
| 2025 Q3 | 351,699 | $833,709 | +$409,291 | $2.37 | 17 |
| 2025 Q2 | 179,153 | $398,820 | -$449,714 | $2.23 | 11 |
| 2025 Q1 | 353,153 | $903,390 | +$543,275 | $2.56 | 9 |
| 2024 Q4 | 140,823 | $1,145,879 | +$1,145,879 | $8.14 | 8 |